跳至主要内容
临床试验/EUCTR2016-003232-21-AT
EUCTR2016-003232-21-AT进行中(未招募)1 期

EffiCacy and safety of topical ketoroLac trOmethamine and sUbtenon triamcinolone acetonideand a watch-and-wait” strategy for acute pseudophakic macular eDema: a randomized phase-3 trial - CLOUD

Medizinische Universität Graz, Univers. Augenklinik0 个研究点目标入组 249 人开始时间: 2017年10月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
249

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - =18 years of age
  • -Pseudophakia in the study eye
  • -No history of previous treatment of PME
  • -Signed written informed consent
  • -Cataract surgery =4 months in study eye
  • -BCVA =20/125; BVCA =20/32
  • -Presence of PME determined by fundus examination
  • -Presence of central macular edema determined by OCT
  • -No sign of significant diabetic retinopathy and/or maculopathy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 25
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 224

排除标准

  • -Pregnancy /Breast-feeding
  • -Systemic treatment with corticosteroids in the preceding 14 days
  • -Systemic treatment with NSAIDs in the preceding 14 days
  • -Presence of any contradictions indicated in the summary of product characteristics for the use of topical ketorolac tromethamine 0.5% and subtenon triamcinolone acetonide injection
  • -Active choroidal neovascularization
  • -Retinal detachment
  • -Vitreoretinal surgery in the preceding year
  • -Myopia =8 diopters
  • -Uncontrolled glaucoma

研究者

发起方
Medizinische Universität Graz, Univers. Augenklinik

相似试验